Regeneron said it began late-stage clinical trials to assess the effectiveness of its antibody cocktail.
Regeneron begins COVID-19 antibody cocktail late-stage trial, shares rise
Leave a reply
- Comment
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Foreaders 